A study analyzing 775 SFTS patients found that a six-biomarker panel and early biomarker trajectories can flag patients at high risk of fatal cardiogenic shock within the first week of hospitalization. The work emphasizes time-sensitive biomarker dynamics rather than late outcome prediction alone. For clinicians managing severe SFTS, earlier identification could support escalation of monitoring and resource allocation during the window when shock risk is still emerging. The dataset-driven approach also suggests a path toward practical severity scores tied to routine bloodwork rather than purely imaging or clinical features.